These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations. Knoben JE, Scott GR, Tonelli RJ. Am J Hosp Pharm; 1990 Dec; 47(12):2696-700. PubMed ID: 2278285 [Abstract] [Full Text] [Related]
6. Investigational new drugs: export requirements for unapproved new drug products. Final rule. Food and Drug Administration, HHS. Fed Regist; 2005 Nov 23; 70(225):70720-30. PubMed ID: 16304736 [Abstract] [Full Text] [Related]
13. The investigative process for new drugs. Nicklas RA. Ann Allergy; 1989 Dec 23; 63(6 Pt 2):598-600. PubMed ID: 2688499 [Abstract] [Full Text] [Related]
15. The FDA's drug review process: ensuring drugs are safe and effective. Meadows M. FDA Consum; 2002 Dec 23; 36(4):19-24. PubMed ID: 12184298 [No Abstract] [Full Text] [Related]
16. Role of follow-on drugs and indications on the WHO Essential Drug List. Cohen J, Cabanilla L, Sosnov J. J Clin Pharm Ther; 2006 Dec 23; 31(6):585-92. PubMed ID: 17176363 [Abstract] [Full Text] [Related]
19. Development and approval of vaccines in the United States. Botstein P. Isr J Med Sci; 1986 Dec 23; 22(3-4):268-71. PubMed ID: 3528047 [Abstract] [Full Text] [Related]